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Several viruses are known to interact with the host
defences either to escape from the immune responses or
to gain advantage of inflammatory mediators to survive.
Human endogenous retroviruses (HERV) are integrated
and are estimated represent up to 8% o the human
genome. An exogenous virus from HERV. W family was
initially isolated from brain cells of patients suffering of
multiple sclerosis and named MSRV [1]. Several lines of
evidence support that its envelope protein (ENV) or its
soluble extra-cellular subunit (ENV-SU) contributes to
inflammation associated with the disease: 1) ENV pro-
motes polyclonal expansion of T lymphocytes [2], 2)
ENV-SU induces human monocytes and dendritic cells
(DC) to produce inflammatory cytokines through engage-
ment of CD14 and TLR4 [3].
In order to study in vivo effects of MSRV, mice were
treated for experimental allergic encephalitis (EAE) induc-
tion, a mouse model for MS, after antigenic myelin pep-
tide immunisation either with complete Freund's
adjuvant or ENV-SU. Clinical score showed significant
EAE symptoms in both mice but no symptoms in control
mice receiving no adjuvant or no ENV (Fig. 1). Cultures of
splenocytes from either ENV-SU or adjuvant treated mice,
recalled with the myelin antigen, led to IFN- production
(not shown), indicating T lymphocyte reactivity towards
the myelin antigen.
To characterise the mode of action of ENV in mice, DC
were cultured from C57BL/6 bone marrow and incubated
with ENV-SU. DC secreted amounts of IL-6 (Fig. 2) and IL-
12p70 (not shown) dose-dependant of the ENV-SU. Flow
cytometry analysis for CMH-II, CD11c, B7.1 and B7.2
molecules DC demonstrated that DC were activated and
underwent further differentiation upon ENV-SU exposure
comparable to other known stimulations. DC derived
from TLR4 (not shown) or CD14 deficient mice (Fig. 3)
were unable to respond to ENV-SU stimulation, arguing
that, as found in humans, TLR4/CD14 pathway is
involved in DC responses in mice.
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Clinical score follow-up of C57BL/6 mice injected with MOG 35-55 and IFA, CFA or ENVFigure 1
Clinical score follow-up of C57BL/6 mice injected 
with MOG 35-55 and IFA, CFA or ENV. Mean values 
were calculated for each group of mice.Page 1 of 2
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by promoting inflammatory response through CD14/
TLR4 pathway, the envelope of MSRV/HERV contributes
to EAE in mice and thus may be one of the key actors of
MS etiology in humans.
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Activation of mouse dendritic cells by the envelopeFigure 2
Activation of mouse dendritic cells by the envelope. 
Bone marrow derived DC were incubated with either 0.5g/
ml or 1g/ml of ENV-SU for 24 h and IL-6 was measured by 
ELISA. Before incubation with the cells, ENV-SU is incubated, 
or not, with the anti-ENV antibodies during 1 h at 4°C. Con-
trol samples are incubated with ENV-SU alone, with LPS or 
without stimulation (NA).
Activation of mouse dendritic cells by the envelope depends on CD14Figure 3
Activation of mouse dendritic cells by the envelope 
depends on CD14. (see legend Fig2). CD14° = CD14 defi-
cient mouse.Page 2 of 2
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